Profesor Psiquiatría
Dirección de correo verificada de usal.es
TítuloCitado porAño
Incidence or sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients.
AL Montejo, G Llorca, JA Izquierdo, F Rico-Villademoros
The Journal of clinical psychiatry, 2001
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients
AL Montejo-Gonzalez, G Llorca, JA Izquierdo, A Ledesma, M Bouso o, ...
Journal of Sex and Marital Therapy 23, 176-194, 1997
Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a …
S Kasper, G Hajak, K Wulff, WJG Hoogendijk, A Luis Montejo, E Smeraldi, ...
Journal of Clinical Psychiatry 71 (2), 109, 2010
Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment.
TA Nutt DJ1, Baldwin DS, Clayton AH, Elgie R, Lecrubier Y, Montejo AL ...
J Clin Psychiatry 67 (suppl 6), 46-49, 2006
Sexual function in chronic illness
R Basson, P Rees, R Wang, AL Montejo, L Incrocci
The journal of sexual medicine 7 (1), 374-388, 2010
Major depressive disorder, antidepressants, and sexual dysfunction.
AH Clayton, AL Montejo
The Journal of clinical psychiatry 67, 33-37, 2006
Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study
J Bobes, J Rejas, M Garcia-Garcia, F Rico-Villademoros, ...
Schizophrenia Research 62 (1-2), 77-88, 2003
Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study
M Bauer, BU Monz, AL Montejo, D Quail, N Dantchev, K Demyttenaere, ...
European Psychiatry 23 (1), 66-73, 2008
Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ …
AL Montejo, N Prieto, A Terleira, J Matias, S Alonso, G Paniagua, S Naval, ...
Journal of psychopharmacology 24 (1), 111-120, 2010
Prolactin awareness: an essential consideration for physical health in schizophrenia
AL Montejo
European Neuropsychopharmacology 18, S108-S114, 2008
Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics
ÁL Montejo, S Majadas, F Rico-Villademoros, G LLorca, J De La Gándara, ...
The journal of sexual medicine 7 (10), 3404-3413, 2010
Duloxetine in the prevention of relapse of major depressive disorder: double-blind placebo-controlled study
DG Perahia, I Gilaberte, F Wang, CG Wiltse, SA Huckins, JW Clemens, ...
The British Journal of Psychiatry 188 (4), 346-353, 2006
Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders
ÁL Montejo, F Rico-Villademoros
Journal of sex & marital therapy 34 (3), 227-239, 2008
The costs of schizophrenia in Spain
J Oliva-Moreno, J López-Bastida, R Osuna-Guerrero, ...
The European Journal of Health Economics 7 (3), 179-184, 2006
The socioeconomic costs of mental illness in Spain
J Oliva-Moreno, J López-Bastida, AL Montejo-González, ...
The European Journal of Health Economics 10 (4), 361-369, 2009
Psychometric characteristics of the psychotropic-related sexual dysfunction questionnaire. Spanish work group for the study of psychotropic-related sexual dysfunctions
AL Montejo, M Garcia, M Espada, F Rico-Villademoros, G Llorca, ...
Actas espanolas de psiquiatria 28 (3), 141-150, 2000
Sexual side-effects of antidepressant and antipsychotic drugs
AL Montejo, L Montejo, F Navarro-Cremades
Current opinion in psychiatry 28 (6), 418-423, 2015
Consenso sobre la salud física del paciente con esquizofrenia de las Sociedades Españolas de Psiquiatría y de Psiquiatría Biológica
SF del Paciente
Actas Esp Psiquiatr 36 (5), 251-264, 2008
Fluoxetine in the prevention of depressive recurrences: a double-blind study
I Gilaberte, AL Montejo, J de la Gandara, V Perez-Sola, M Bernardo, ...
Journal of clinical psychopharmacology 21 (4), 417-424, 2001
Generalized anxiety disorder, with or without co-morbid major depressive disorder, in primary care: prevalence of painful somatic symptoms, functioning and health status
I Romera, S Fernández-Pérez, ÁL Montejo, F Caballero, L Caballero, ...
Journal of affective disorders 127 (1-3), 160-168, 2010
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20